Clyno Platform | Version 3.1 | Effective: 18 July 2026
Krilax Innovations Private Limited ("Company", "we", "us", "our")
1.1. Clyno is a cloud-based, AI-powered healthcare practice management platform developed and operated by Krilax Innovations Private Limited, a company incorporated under the laws of India.
1.2. The Platform enables clinics, hospitals, and individual medical practitioners to streamline their outpatient department (OPD) workflows through intelligent patient registration, queue management, AI-assisted consultation support, digital prescription generation, patient report analysis, pharmacy management, and comprehensive analytics.
1.3. Clyno leverages advanced artificial intelligence to provide clinical decision support, including diagnosis suggestions, drug interaction checks, prescription recommendations, and patient report analysis — all designed to assist (not replace) the treating physician's clinical judgment.
1.4. The Platform is built on enterprise-grade Microsoft Azure infrastructure hosted in India, ensuring data sovereignty, high availability, and compliance with Indian data protection regulations.
1.5. Acceptance: By registering for, accessing, or using the Platform, you confirm that you have read, understood, and agree to be bound by these Terms. If you accept these Terms on behalf of a clinic, hospital, or other organization, you represent and warrant that you are at least 18 years of age and have the authority to bind that organization.
1.6. The Platform includes companion applications (such as waiting-room displays and patient-facing applications for appointment booking and visit records). Use of patient-facing applications by patients is subject to the applicable in-app terms and the privacy practices described in Section 5; the treating Clinic remains the Data Fiduciary for all clinical records.
2.1. "User" means any individual who accesses the Platform under a defined role with specific permissions, including doctors, clinic staff, administrators, marketing personnel, support agents, and — where a clinic participates in a partnership program under Section 15 — authorized pharmaceutical partner personnel.
2.2. "Clinic" means any medical clinic, hospital, or healthcare facility registered on the Platform by a subscribing organization. A single organization may operate multiple clinics.
2.3. "Patient" means any individual whose personal and medical information is recorded on the Platform by a Clinic for the purpose of healthcare delivery.
2.4. "Platform" means the Clyno software-as-a-service application, including all web-based interfaces, mobile applications, APIs, backend services, and associated documentation provided by the Company.
2.5. "AI Features" means all artificial intelligence and machine learning capabilities of the Platform, including but not limited to prescription suggestions, diagnosis hints, patient symptom analysis, report analysis, drug interaction checks, differential diagnoses, dosage recommendations, and any other AI-assisted content generation.
2.6. "Subscription" means the paid or trial access plan selected by a Subscriber that determines the features, usage limits, and billing terms applicable to their use of the Platform.
2.7. "Subscriber" or "You" means the individual, clinic, hospital, or organization that registers for and uses the Platform.
2.8. "Prescriber" means any registered medical practitioner who uses the Platform to generate, review, or issue prescriptions, diagnoses, or treatment plans to patients.
2.9. "Patient Data" means any personal information, medical records, health data, consultation notes, prescriptions, lab reports, and any other data relating to patients entered into or generated by the Platform.
2.10. "Confidential Information" means all proprietary information disclosed by either party including business processes, algorithms, technical data, and trade secrets.
2.11. "Add-on Packs" means prepaid consumable credits purchased in addition to a Subscription, including WhatsApp message credit packs and AI usage credit packs, which are consumed as the corresponding feature is used.
2.12. "Fees" means the subscription charges, Add-on Pack charges, and applicable taxes payable by the Subscriber, as published on the Platform's pricing page or agreed in a separate written order.
CRITICAL MEDICAL DISCLAIMER — PLEASE READ CAREFULLY
3.1. Clyno provides AI-powered decision support tools designed to assist qualified medical practitioners. All AI-generated content — including prescription suggestions, diagnosis hints, drug recommendations, dosage calculations, drug interaction alerts, differential diagnoses, report analysis, and treatment plans — is strictly advisory in nature.
3.2. AI suggestions are NOT medical advice. The Platform does not practice medicine, provide medical opinions, or establish a doctor-patient relationship. AI outputs are generated by machine learning models and may be inaccurate, incomplete, outdated, clinically inappropriate, or potentially harmful.
3.3. The treating physician bears full clinical responsibility for every medical decision, prescription, diagnosis, and treatment plan issued to any patient. Under no circumstances does the use of AI Features transfer, diminish, or share this responsibility with the Company, its affiliates, employees, agents, or technology partners.
3.4. Krilax is not liable for clinical decisions made using AI suggestions. The Company, its directors, officers, employees, affiliates, technology partners, and service providers are expressly excluded from all liability — whether in contract, tort (including negligence), strict liability, or otherwise — for any adverse clinical outcomes, misdiagnoses, medication errors, adverse drug reactions, patient harm, injury, death, or any other consequence arising from reliance on AI-generated content.
3.5. AI Features include:
3.6. All AI outputs must be independently verified by a qualified medical professional before being acted upon. AI outputs may not account for the patient's complete medical history, concurrent medications, allergies, contraindications, genetic factors, or the latest clinical guidelines.
3.7. By using the AI Features, the Prescriber warrants that they: (a) possess all requisite medical qualifications, licensing, and registration as mandated by the National Medical Commission Act, 2019 and applicable state medical council regulations; (b) maintain active and valid medical registration; and (c) are competent to independently evaluate and override any AI-generated suggestion.
3.8. The AI models are periodically updated and retrained. The Company does not guarantee the consistency, accuracy, or clinical validity of AI outputs across different versions. Past accuracy does not guarantee future accuracy.
AI-ASSISTED ANALYSIS DISCLAIMER
4.1. The Platform may provide AI-assisted analysis of patient symptoms, lab reports, imaging reports, and other clinical data ("Analysis Features"). These analyses are preliminary, machine-generated interpretations only and do not constitute medical diagnoses or clinical opinions.
4.2. Patient symptom notes, history summaries, and clinical observations generated by the Platform are AI-generated drafts that must be reviewed, edited, and validated by the treating physician before being relied upon for any clinical decision.
4.3. Lab report interpretations, abnormal value flagging, and trend analyses provided by the Platform are based on general reference ranges and may not account for patient-specific variables including age, gender, ethnicity, pregnancy status, concurrent conditions, or laboratory-specific calibration differences.
4.4. The Prescriber must independently verify all AI-generated analysis against original source documents and their own clinical assessment. The Company accepts no responsibility for clinical decisions made based on AI-generated analysis without independent verification.
4.5. The Platform does not provide real-time critical value alerts for life-threatening conditions. Prescribers must rely on their own clinical judgment and established emergency protocols for urgent medical situations.
5.1. Data Controller: The subscribing clinic or organization is the Data Fiduciary (data controller) under the Digital Personal Data Protection Act, 2023 ("DPDP Act"). The clinic determines the purposes and means of processing Patient Data.
5.2. Data Processor: Krilax Innovations Pvt. Ltd. acts as a Data Processor and processes Patient Data only as instructed by the subscribing clinic and as necessary to provide the Platform services.
5.3. Data Storage Location: All data is stored in India, in Microsoft's India cloud regions, ensuring full compliance with Indian data localization requirements.
5.4. Encryption: All data is protected with 256-bit TLS encryption for data in transit and AES-256 encryption at rest. Database connections are secured with SSL/TLS certificates.
5.5. Access Control: The Platform implements role-based access control (RBAC) — every User operates under a defined role with granular, least-privilege permissions scoped to their function. Secure token-based authentication and audit logging ensure accountability.
5.6. Patient's Right to Access: Patients may request access to their medical records through their treating clinic. The clinic, as the Data Fiduciary, is responsible for responding to such requests in accordance with the DPDP Act.
5.7. Patient's Right to Erasure: Patients may request deletion or anonymization of their data through their clinic administrator. Such requests are subject to minimum legal retention requirements under healthcare regulations.
5.8. Data Retention: Medical records are retained for a minimum of 3 years in line with the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002, as continued under the National Medical Commission framework, and other applicable healthcare regulations. Technical activity logs are retained for 90 days, and payment records for at least 365 days or as required by tax law.
5.9. Data Breach Notification: Krilax will notify affected clinics within 72 hours of discovering a data breach, along with details of the nature of the breach, the data affected, and remedial measures taken.
5.10. Sub-processors: The following third-party sub-processors are used in the delivery of the Platform services:
5.11. The Company does not sell, rent, lease, or share Patient Data with any third party for marketing, advertising, or any non-service purpose.
5.12. No AI Training on Patient Data: Patient Data is not used to train AI models — neither by the Company nor by its AI sub-processors. The Company may use anonymized, aggregated, de-identified statistics (which cannot identify any individual patient or Subscriber) solely for operating, securing, and improving the Platform.
5.13. Subscriber's Consent Obligations: The Clinic, as Data Fiduciary, is responsible for providing patients with any legally required notice and for obtaining any legally required consent for (a) recording their personal and health data on the Platform, and (b) receiving digital communications (such as WhatsApp, SMS, or email notifications, prescriptions, and follow-up reminders) initiated by the Clinic through the Platform.
5.14. Usage & Technical Data: The Company collects technical and usage information about how the Platform is used (such as feature usage, session activity, device and log data) to operate, secure, support, bill, and improve the service. This information is handled per this Section and is not sold or used for third-party advertising.
6.1. Prescriptions generated through the Platform are computer-aided, not computer-generated. The AI assists the doctor in creating prescriptions, but every prescription requires the doctor's active review, modification, and approval before issuance.
6.2. The doctor's medical registration number (State Medical Council / National Medical Commission registration) is required for prescription generation. Prescriptions display the doctor's name, qualifications, registration number, and clinic details as mandated by regulatory guidelines.
6.3. The Platform is designed for in-clinic OPD (Outpatient Department) use and is not a telemedicine platform. It does not facilitate remote consultations, video calls, or teleconsultation services as defined under the Telemedicine Practice Guidelines issued by the Board of Governors (MCI).
6.4. Clinics are responsible for maintaining medical records as per applicable medical council regulations, including proper documentation of patient consultations, prescriptions, and treatment plans. The Platform provides tools to facilitate compliance but does not guarantee regulatory compliance on behalf of the clinic.
6.5. The Platform does not replace the requirement for physical examination of patients. All consultations facilitated through the Platform are intended to be conducted in-person at the clinic premises.
7.1. Plans & Pricing: The Platform is offered under the plans (including any free trial) published on the Platform's pricing page. The features, limits (such as the number of doctors), and price applicable to your Subscription are those displayed at checkout at the time of purchase (or set out in a separate written order for Enterprise plans). Published pricing may be revised prospectively; revisions never change the price of a billing period you have already paid for.
7.2. Billing Cycles: Subscriptions are available in Monthly, Quarterly, Half-yearly, and Yearly billing cycles. Longer billing cycles may include discounted pricing.
7.3. GST: Goods and Services Tax at the prevailing rate (currently 18% for SaaS services) is applicable on all subscription fees as per Indian tax law (SAC Code: 998314 — Information Technology Software Services).
7.4. All payments are processed securely through Razorpay or such other payment gateway as the Company may designate. All prices are denominated in Indian Rupees (INR). Any payment gateway or convenience fee, if applicable, will be shown at checkout before you pay. The Company does not store your card or banking credentials.
7.5. Auto-renewal: Subscriptions do not auto-renew. Manual renewal is required before the expiry of the current billing cycle to maintain uninterrupted access to the Platform.
7.6. Plan upgrades during an active billing cycle are processed immediately, with unused days from the current plan credited on a pro-rata basis towards the upgraded plan. Plan downgrades take effect at the start of the next billing cycle.
7.7. Free trial periods provide full access to plan features for the specified duration. No credit card or payment information is required for trial registration. The Company reserves the right to modify or discontinue trial offerings at any time.
7.8. Failure to pay subscription fees by the due date may result in suspension or restriction of access to the Platform. The Company shall not be liable for any data loss or business interruption arising from such suspension.
7.9. Add-on Packs: WhatsApp message credits, AI usage credits, and similar Add-on Packs are prepaid consumables. Credits are deducted as the corresponding feature is used, do not carry a cash value, are non-transferable between organizations, and are subject to any validity period stated at the time of purchase.
REFUND TERMS
8.1. 7-Day Free Trial: No payment is required during the trial period. Since no payment is collected, no refund is applicable for trial accounts.
8.2. Full Refund (within 7 days): Paid subscriptions are eligible for a full refund within 7 days of purchase if the Subscriber is not satisfied with the service. No questions asked.
8.3. Pro-rata Refund (after 7 days): After the initial 7-day window, Subscribers may request a pro-rata refund for the remaining unused period of their subscription. The refund amount is calculated on a daily basis from the date the refund request is received.
8.4. Refund Processing: Approved refunds are processed within 5-10 business days to the original payment method used at the time of purchase.
8.5. Non-refundable Items: The following are not eligible for refund:
8.6. How to Request a Refund: Send an email to contact@clyno.in with your registered email address and order/transaction ID. The support team will acknowledge your request within 24 hours and process it as per the terms above.
8.7. The Company reserves the right to deny refund requests in cases of fraud, abuse, or violation of these Terms of Service.
9.1. Target Uptime: The Company targets 99.9% uptime for the Platform, excluding scheduled maintenance windows. Uptime is calculated on a monthly basis.
9.2. Scheduled Maintenance: Planned maintenance activities are communicated at least 24 hours in advance via email to the Subscriber's registered email address. Maintenance is typically scheduled during off-peak hours (11:00 PM to 5:00 AM IST).
9.3. Emergency Maintenance: Emergency maintenance may be performed without prior notice when necessary to protect the integrity, security, or availability of the Platform.
9.4. Support Response Times:
9.5. Data Backup: Daily automated backups are performed with a 30-day retention period. Backups are stored in geographically redundant storage within India.
9.6. The Company is not responsible for downtime caused by factors outside its control, including internet connectivity issues at the Subscriber's end, browser incompatibilities, or third-party service outages.
9.7. The uptime and response targets in this Section are service goals, not guarantees. Unless expressly agreed in a separate signed Enterprise agreement, no service credits, penalties, or refunds accrue from missing a target.
9.8. Third-party Message Delivery: Delivery of WhatsApp, SMS, and email messages depends on third-party networks and the recipient's device, number, and settings. The Company will make commercially reasonable efforts to hand messages to the delivery provider but does not guarantee receipt. Clinics should not rely on digital delivery alone for urgent or clinically critical communication.
INDEMNIFICATION & HOLD HARMLESS
10.1. The Prescriber and the Subscriber jointly and severally agree to indemnify, defend, and hold harmless the Company, its directors, officers, employees, affiliates, agents, and service providers from and against any and all claims, demands, actions, suits, proceedings, losses, damages, liabilities, costs, and expenses (including reasonable legal fees) arising from or related to:
10.2. The Subscriber acknowledges that the Company provides a technology platform only and does not practice medicine, provide medical advice, or establish a doctor-patient relationship. The entire doctor-patient relationship, duty of care, and clinical responsibility rests exclusively with the Prescriber.
10.3. The Prescriber shall maintain adequate professional indemnity insurance as required by applicable medical regulations.
10.4. This indemnification obligation shall survive the termination or expiration of these Terms.
11.1. Platform Ownership: All intellectual property rights in the Platform — including source code, algorithms, AI models, user interface designs, documentation, trademarks, and trade secrets — are and shall remain the exclusive property of Krilax Innovations Pvt. Ltd.
11.2. Clinic Data Ownership: The subscribing clinic or organization retains full ownership of all Patient Data entered into the Platform. The Company claims no ownership over Patient Data.
11.3. Doctor's Content: Doctors retain ownership of their custom prescription templates, personal formulary, and clinical notes created on the Platform.
11.4. Drug Database: The drug database available on the Platform is licensed for use within the Platform only. Subscribers may not extract, copy, or redistribute the drug database for any purpose outside the Platform.
11.5. The Subscriber is granted a limited, non-exclusive, non-transferable, revocable licence to use the Platform for the duration of their active subscription, solely for its intended purpose.
11.6. Feedback, suggestions, or feature requests submitted by the Subscriber may be used by the Company to improve the Platform without obligation of compensation or attribution.
12.1. THE PLATFORM IS PROVIDED ON AN "AS IS" AND "AS AVAILABLE" BASIS WITHOUT WARRANTIES OF ANY KIND, whether express, implied, or statutory.
12.2. Krilax is not liable for:
12.3. Maximum Liability: The Company's aggregate liability for all claims arising under or in connection with these Terms shall not exceed the total subscription fees actually paid by the Subscriber in the twelve (12) months immediately preceding the event giving rise to the claim.
12.4. IN NO EVENT SHALL THE COMPANY BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, PUNITIVE, OR EXEMPLARY DAMAGES, INCLUDING DAMAGES FOR LOSS OF PROFITS, REVENUE, DATA, GOODWILL, OR BUSINESS OPPORTUNITY.
12.5. Force Majeure: The Company shall not be liable for any loss, damage, or service disruption arising from events beyond its reasonable control, including but not limited to acts of God, natural disasters, pandemics, government actions, armed conflict, internet or telecommunications failures, power outages, third-party service provider failures, cyberattacks, or any other force majeure event.
12.6. The limitations in this Section shall apply regardless of the legal theory and shall survive termination of these Terms.
13.1. The Subscriber is responsible for maintaining the confidentiality and security of all account credentials. The Subscriber must immediately notify the Company of any suspected unauthorized access.
13.2. Each user must have their own unique account. Sharing login credentials is strictly prohibited. The Subscriber is responsible for all activities conducted under its user accounts.
13.3. The Platform must be used exclusively for legitimate healthcare practice management purposes. The following uses are strictly prohibited:
13.4. Accounts may be immediately suspended or terminated, without prior notice, for security violations, breach of these Terms, or activities that threaten Platform integrity.
13.5. Each User represents that they are at least 18 years of age, that the registration and profile information they provide (including medical qualifications and registration numbers, where applicable) is accurate and kept up to date, and that they will use the Platform only within the scope of their assigned role.
14.1. Either party may terminate the subscription with 30 days written notice to the other party.
14.2. On Termination: The clinic's data will be made available for export within 30 days of termination in a machine-readable format. After the export window, data will be permanently deleted within 90 days, subject to legal retention requirements.
14.3. Immediate Termination by Company: Krilax may terminate or suspend access immediately and without notice for:
14.4. Upon termination, the Subscriber's access shall be immediately revoked. Sections relating to limitation of liability, indemnification, intellectual property, data obligations, and governing law shall survive termination.
14.5. Dormant Trial Accounts: Trial accounts that are not converted to a paid Subscription and remain inactive for an extended period may be deactivated and their data deleted after at least 30 days' prior notice to the registered email address, subject to the retention requirements of Section 5.
TRANSPARENCY DISCLOSURE
15.1. Some clinics on the Platform may be sponsored by pharmaceutical companies as part of partnership programs. In such cases, the pharmaceutical company may subsidize or fully fund the clinic's subscription to the Platform.
15.2. AI prescription suggestions may include partner brand medicines where clinically appropriate. However, these suggestions are generated based on clinical relevance and are clearly presented alongside generic alternatives.
15.3. The doctor retains full and absolute discretion over the final prescription. No pharmaceutical partner may override, restrict, or mandate the doctor's prescription choices. The doctor may freely prescribe any medicine — whether partner brand, generic, or any other brand — based solely on their clinical judgment.
15.4. This disclosure is made transparently to maintain clinical independence and to comply with ethical guidelines issued by the National Medical Commission regarding pharmaceutical industry interactions with healthcare professionals.
15.5. No Patient-identifiable Data to Partners: Pharmaceutical partners never receive patient-identifiable data. Any insights shared with a partner are aggregated and de-identified. Doctors may withdraw from partner data-sharing at any time through their Platform settings, in line with the DPDP Act's right of withdrawal.
15.6. Patients and healthcare professionals who have concerns about pharmaceutical partnerships may contact contact@clyno.in for further information.
16.1. These Terms shall be governed by and construed in accordance with the laws of India, without regard to conflict of law principles.
16.2. Good-Faith Negotiation: Any dispute arising out of or in connection with these Terms shall first be attempted to be resolved through good-faith negotiation between the parties for a period of thirty (30) days.
16.3. Arbitration: If the dispute cannot be resolved through negotiation, it shall be referred to and finally resolved by arbitration in accordance with the Arbitration and Conciliation Act, 1996 (as amended). The seat of arbitration shall be Nashik, Maharashtra, India. The arbitration shall be conducted in English by a sole arbitrator mutually appointed by the parties.
16.4. Jurisdiction: The courts in Nashik, Maharashtra, India shall have exclusive jurisdiction for any proceedings not subject to arbitration.
16.5. Notwithstanding the above, either party may seek injunctive or other equitable relief from any court of competent jurisdiction to prevent irreparable harm.
17.1. The Company reserves the right to amend these Terms at any time. Material changes shall be communicated to Subscribers via email or in-Platform notification at least 15 days before they take effect, except where a change is required sooner by law or to address a security risk.
17.2. Continued use of the Platform after the effective date of any amendment constitutes acceptance of the revised Terms. If the Subscriber does not agree to a material change, they may terminate under Section 14 and receive a pro-rata refund of prepaid, unused fees under Section 8.
17.3. The most current version of these Terms, with its version number and effective date, is always available at the Platform's Terms of Service page.
18.1. Entire Agreement: These Terms, together with the order/checkout details of your Subscription and any separately signed Enterprise agreement, constitute the entire agreement between the parties regarding the Platform and supersede all prior discussions and understandings. In case of conflict, a signed Enterprise agreement prevails over these Terms.
18.2. Severability: If any provision of these Terms is held invalid or unenforceable, that provision shall be enforced to the maximum extent permissible and the remaining provisions shall remain in full force.
18.3. No Waiver: Failure or delay by either party to enforce any right under these Terms shall not constitute a waiver of that right.
18.4. Assignment: The Subscriber may not assign or transfer these Terms or the Subscription without the Company's prior written consent. The Company may assign these Terms in connection with a merger, acquisition, corporate reorganization, or sale of substantially all of its assets, provided data-protection commitments under Section 5 continue to apply.
18.5. Notices: Notices to the Subscriber are validly given by email to the organization's registered email address or by in-Platform notification. Notices to the Company must be sent to contact@clyno.in.
18.6. Relationship: The parties are independent contractors. Nothing in these Terms creates a partnership, joint venture, employment, or agency relationship.
18.7. No Third-party Beneficiaries: Except as expressly stated, these Terms confer no rights on any person other than the parties. Patients are not parties to these Terms; their rights in respect of their data are exercised through the treating Clinic as described in Section 5.
18.8. Survival: Provisions which by their nature should survive termination — including Sections 3, 4, 10, 11, 12, 16, and this Section — shall so survive.
18.9. Headings: Section headings are for convenience only and do not affect interpretation.
Krilax Innovations Private Limited
For legal inquiries: contact@clyno.in
For support: contact@clyno.in
Grievance & data protection concerns: contact@clyno.in (mark the subject line "Grievance"). We acknowledge grievances within 48 hours and aim to resolve them within 30 days, in line with applicable Indian regulations.
Website: www.krilax.com
Krilax Innovations Private Limited
For legal inquiries: contact@clyno.in | For support: contact@clyno.in
Website: www.krilax.com
Version 3.1 | Last updated: 18 July 2026